Eyenovia
New York, New York, United States · Blockchain, Cryptocurrency, Finance · 13 employees
Eyenovia, Inc. is a pioneering digital ophthalmic technology company and the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE. With this dual focus, Eyenovia continues to revolutionize topical eye treatment while providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-g
Funding history
- Funding Round — $50.0M — Jun 2025
- Funding Round — $6.0M — Apr 2020
- Funding Round — $6.0M — Aug 2017
- Series seed — $4.0M — Aug 2016
Recent signals
- Jun 08, 2026: Hyperion DeFi, Inc. Reaffirms 2026 Financial Guidance Despite Ending Partnerships with Native Markets and Felix Markets.
- Jan 05, 2026: Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer
- Oct 31, 2025: Hyperion DeFi Enters Joint Validator Operators' Agreement with Kinetiq Group and Pier Two
- Oct 27, 2025: SEC 8-K (1.01): On October 27, 2025, Hyperion DeFi, Inc. entered into a Joint Validator Operators’ Agreement with Kinetiq Research Pte. Ltd. and Pier Two Pty Ltd, which formalizes their collaboration to operate a co-branded validator node on the Hyperliquid Layer-1 blockchain. The agreement is effective retroactively from June 25, 2025, indicating that it aims to enhance the operational capabilities of the blockchain. Hyperion will initiate the validator with 10,000 HYPE tokens and will provide additional staking capital from its treasury to ensure the validator's active participation in the consensus protocol. This collaboration is expected to strengthen Hyperion's position in the blockchain space and expand its user engagement through improved staking functionalities.
- Sep 29, 2025: Hyperion DeFi Appoints David Knox as Chief Financial Officer
- Jun 18, 2025: Raised $50.0M
- Jan 06, 2025: Launched Eyenovia Inc. Engages Chardan for Strategic Alternatives Review Amid Optejet Development
- Dec 06, 2024: Eyenovia, Inc. Partners with Healthcare Focused Institutional Investor for $1.9 Million Registered Direct Offering
See plans & pricing → Track Eyenovia’s funding, hiring, and signals — with verified contacts — on Fundz.